Changes

**Clinical resolution occurred in 92% of patients (89% after a single treatment), without serious adverse effects.

**Clinical resolution occurred in 92% of patients (89% after a single treatment), without serious adverse effects.

**A recent review of 536 patients reported a 27% clinical response rate.

**A recent review of 536 patients reported a 27% clinical response rate.

**A randomized trial of fecal microbiota transplantation demonstrated symptom

**A randomized trial of fecal microbiota transplantation demonstrated symptom resolution in 94% of patients who received vancomycin for s days followed by either one or two treatments with fecal microbiota transplantation, versus 31% in those receiving vancomycin alone for 14 days, and 23% for those receiving vanconycin for 14 days plus bowel lavage. This study was stopped early after interim analyses demonstrated superiority of fecal microbiota transplantation, Among 18 patients in the other treatment groups who received subsequent fecal microbiota transplantation 83% had symptom resolution

resolution in 94% of patients who received vancomycin for s days followed by either

one or two treatments with fecal microbiota transplantation, versus 31% in those

receiving vancomycin alone for 14 days, and 23% for those receiving vanconycin for

14 days plus bowel lavage. This study was stopped early after interim analyses

demonstrated superiority of fecal microbiota transplantation, Among 18 patients in

the other treatment groups who received subsequent fecal microbiota transplantation

83% had symptom resolution